Our Pediatric Blood Cancer Program treats all childhood blood cancers, including leukemias, lymphomas, and rare conditions such as juvenile myelomonocytic leukemia (JMML). The program offers advanced therapies, including bone marrow transplants and CAR T‑cell therapy for eligible patients.
Our Solid Tumor Program cares for children, teens, and young adults with solid tumors such as neuroblastoma, hepatoblastoma, bone and soft tissue sarcomas, Wilms’ tumor, and relapsed disease. Special focus is given to high‑risk, rare, and relapsed tumors, with access to clinical trials and specialized treatments.
Our Brain Tumor Program treats children with primary brain and central nervous system tumors. Specialty care is also available for genetic conditions that increase tumor risk, including neurofibromatosis type 1 (NF‑1) and schwannomatosis.
Our Pediatric Hereditary Cancer Clinic evaluates and cares for children who carry genetic mutations that increase their lifetime risk of cancer. Services include genetic counseling, testing, and coordination with other specialty clinics.